These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9364742)

  • 1. Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog.
    Naitoh T; Mishima M; Kawaguchi S; Matsui K; Andoh T; Kagei K; Kakiki M; Yuzuriha T; Horie T
    Xenobiotica; 1997 Oct; 27(10):1053-70. PubMed ID: 9364742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in rat.
    Naitoh T; Kakiki M; Kozaki T; Mishima M; Yuzuriha T; Horie T
    Xenobiotica; 1997 Oct; 27(10):1071-89. PubMed ID: 9364743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences and mechanism of the epimerization of a new MAO-A inhibitor.
    Naitoh T; Kawaguchi S; Kakiki M; Ohe H; Kajiwara A; Horie T
    Xenobiotica; 1998 Mar; 28(3):269-80. PubMed ID: 9574815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pharmacokinetic studies to a novel antidepressant, E2011.
    Naitoh T; Horie T; Nagato S; Kagaya T; Kubota A; Akasaka K
    Xenobiotica; 1994 Aug; 24(8):819-26. PubMed ID: 7839704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
    Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
    Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological response of rats to a novel monoamine oxidase type-A inhibitor, (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5- methoxymethyl-2-oxazolidinone (E2011), orally administered for 13 weeks.
    Sato G; Chimoto T; Aoki T; Hosokawa S; Sumigama S; Tsukidate K; Sagami F
    J Toxicol Sci; 1999 Aug; 24(3):165-75. PubMed ID: 10478331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
    Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
    Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
    Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.
    Akiyama H; Kudo S; Shimizu T
    Arzneimittelforschung; 1985; 35(7A):1124-32. PubMed ID: 4074423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.